Never miss a story

Get subscribed to our newsletter

Blood from people who have recovered from COVID-19 may help treat or prevent the disease in others. Pixabay

By Steve Baragona

Blood from people who have recovered from COVID-19 may help treat or prevent the disease in others. This is a health news.

Scientists are preparing to see if injecting patients with the clear liquid part of blood, known as plasma, from patients who have recuperated from coronavirus infection can halt the virus.

It’s an age-old treatment, used for more than a century against various outbreaks, from the 1918 influenza pandemic to measles in the 1930s to Ebola in 2014.

When patients recover from a disease, their blood contains antibodies to the germ that caused it. Antibodies are like the immune system’s warning flags. When a germ infects a patient again, those warning flags draw the immune system’s attention to the invader, and the body can fight it off.

A worker checks bottles with blood plasma derivatives at the Octapharma company in Dessau, Germany. VOA

Injecting patients with convalescent serum can pass on that protection.

“If you can harvest those antibodies and give them to people that either have been exposed [to the germ] and therefore are at risk, or are early on in the disease, then you have a good chance of making a difference,” said Dr. Shmuel Shoham, an associate professor of medicine at Johns Hopkins University School of Medicine.

Not a sure thing

It doesn’t always work, however.

Shoham did a study to see if plasma from recovered influenza patients would help people with moderate to severe flu.

It didn’t.

But Shoham hasn’t given up hope that convalescent serum could help fight COVID-19, in part because the patients in his influenza study may have been too far along in their illness.

Bags of donated blood plasma are pictured in Seoul, South Korea. VOA

“When you’re trying to treat a disease that’s later on, when it’s too deep into the tissues, other parts of the immune system are important,” he said. “So maybe in the influenza patients we were getting it too late. They already had disease inside of them.”

Shoham says it may work as prevention for people at high risk, such as health care workers. Vaccines work by triggering the immune system to produce antibodies against a weakened or dead version of a germ. Plasma would provide those antibodies, but only temporarily. Patients receiving the plasma aren’t producing their own antibodies, so protection would eventually wear off.

Chinese physicians treated some patients with convalescent plasma, but not in controlled clinical studies, so it’s not clear how well it worked.

Call for plasma

Chinese authorities have called for more citizens who have recovered from COVID-19 to donate plasma.

Passengers arrive from a domestic flight at Beijing Capital Airport on March 27, 2020. – China will drastically cut its international flight routes and bar entry to returning foreigners based in the country to stem the spread of the COVID-19 coronavirus, authorities. VOA

“I hope everyone can do his share to help end the epidemic as soon as possible,” said Xiong Fei, a bus driver in Wuhan, who caught the virus while treating his mother, who died of the disease, according to China’s state-run broadcaster, CCTV.

Blood banks routinely collect plasma for use in surgeries and emergency rooms.

Spanish health care company Grifols has signed an agreement with the U.S. government to collect plasma at the company’s U.S. blood donation centers. It is also planning to purify coronavirus antibodies from plasma for further clinical testing against the disease.

FDA approval

The U.S. Food and Drug Administration this week authorized doctors to use convalescent plasma on an emergency basis.

Also Read- Google Brings a New Update to its Chat App Duo

“Now, this is a possible treatment. This is not a proven treatment. Just want to emphasize that,” FDA Commissioner Stephen Hahn said at a press conference.

More testing is needed to find out if treating patients with convalescent serum is safe and effective. (VOA)



Doris Lessing who won a Nobel Prize in Literature

London (CNN)- At five o'clock in the morning, the esteemed 86-year-old astrophysicist Jim Peebles was woken suddenly by the telephone ringing.

"In previous experience, the only phone calls at that time of night are bad news," he said. This one was great news. "The opening sentence from the caller was: 'The Nobel committee has voted to award you the Nobel Prize in Physics. Do you accept?'" Peebles recalled. The wording threw him. Who wouldn't accept a Nobel Prize? "You know the Bob Dylan fiasco?" he said during a phone interview with CNN. "That might have put the wind up them."The "fiasco" Peebles mentions refers to the 2016 Nobel Prize in Literature, which was controversially given to an utterly unimpressed Dylan.Aside from being ever-presents on college campuses in the 1960s, little connects Peebles, an expert in theoretical cosmology, with Dylan. But one of the starkest contrasts might lie in their reactions to winning a Nobel -- and the songwriter is far from the only laureate whose crowning turned out to be an awkward affair.

The five committees are notoriously secretive, fiercely shielding their choices from the outside world -- including the laureates themselves, who are told of their victories just minutes before they are announced to the public.

Keep Reading Show less
Wikimedia Commons

Sindoor implies the longevity of a woman's marriage to her husband in the Hindu tradition

Married Hindu women are recognised by a red streak of vermillion in the middle of their foreheads. This is traditionally called 'sindoor', which is derived from the Sanskrit word sindura, meaning 'red lead.'. Sindoor is traditionally powdered turmeric and lime, sometimes red saffron, or red sandalwood. It is also called vermilion, or Kumkum.

Vermilion powder mixed on a plate Sindoor is traditionally powdered turmeric and lime, sometimes red saffron, or red sandalwood. It is also called vermilion, or Kumkum. Image source: Photo by Gayathri Malhotra on Unsplash

Keep Reading Show less
Wikimedia Commons

Actress Urvashi Rautela has recently announced the name of her next film which is titled 'Dil Hai Gray'.

Actress Urvashi Rautela has recently announced the name of her next film which is titled 'Dil Hai Gray'. It's a Hindi remake of Tamil film 'Thiruttu Payale 2'. Urvashi Rautela will be seen alongside Vineet Kumar Singh and Akshay Oberoi.

Urvashi shares: "I am excited to announce the title of my next film 'Dil Hai Gray' on the auspicious day of Vijaya Dashami. The film is very close to my heart and it was lovely working with director Susi Ganeshan sir, producer M Ramesh Reddy sir, and my co-stars Vineet Kumar Singh and Akshay Oberoi. "

"The film has created a massive response in the south industry and I am very positive about the story that it will be also be loved by the audience here. I hope my fans would bless us with their love and support. Super excited to watch my film on the big screen after a long time," she concludes. (IANS/ MBI)

Keep reading... Show less